Arthneeti
VO

Valiant Organics Ltd

Q2 FY26Chemicals & Petrochemicals

Valiant Organics Q2 FY26 earnings call: Revenue & Margins

Q2 FY26 investor presentation: what the company reported on revenue, margins and projects.

Price₹411
Market cap₹1.2K Cr
P/E23.7
Updated24 Sept 2026
Read4 min read

Based on Valiant Organics Ltd's Q2 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.

The short version

Q2-FY26 consolidated revenue from operations: INR 1,573 million, down 1.8% year-on-year (Page 12). Q2-FY26 Consolidated Financial Highlights: - EBITDA: INR 212 Mn (up from INR 24 Mn in Q2-FY25) - Operating EBITDA Margin: 13.48% (up from 1.50% in Q2-FY25) - PAT: INR 57 Mn (compared to a loss of INR 125 Mn in Q2-FY25) - PAT Margin: 3.62% (compared to -7.80% in Q2-FY25) - Year-on-year change shows a significant turnaround in profitability and margin expansion.

From Valiant Organics Ltd's Q2 FY26 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • Q2-FY26 consolidated revenue from operations: INR 1,573 million, down 1.8% year-on-year (Page 12).
  • Q2-FY26 standalone revenue from operations: INR 1,572 million, down 1.9% year-on-year (Page 14).
  • Q2-FY26 sales volumes by chemistry (MT):
  • Chlorination: 274 MT (Page 11)
  • Hydrogenation: 394 MT
  • Ammonolysis: 286 MT
  • Others: 97 MT
  • Volume break-up H1-FY26 (Page 10): Chlorination 29%, Hydrogenation 43%, Ammonolysis 26%, Others 2%.
  • Year-on-year volume growth not explicitly stated.

2 more points management made on revenue & sales performance

Profitability & Margins

See what Valiant Organics Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

The investor presentation does not explicitly state any details regarding capex, capacity expansion, new plants, or projects with amounts, statuses, or timelines. The document primarily focuses on historical and current financial performance, operational highlights, manufacturing footprint, business strengths, shareholding pattern, and disclaimer information. While capacities of existing manufacturing facilities at various locations (Sarigam, Vapi, Tarapur, Jhagadia units 1 & 2, Ahmedabad) are described, no specific upcoming expansions, projects, or capital expenditure plans are mentioned.

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

5x potential
1Shiv Texchem
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Valiant Organics Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The provided investor presentation for Valiant Organics Limited does not mention or report any details on order books, order inflows, or pending orders. The document focuses on financial performance, balance sheets, income statements, operational highlights, revenue break-ups by chemistry and end-user industry, and shareholding patterns without reference to order status or backlog metrics.

Valiant Organics Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹218 Cr, net profit ₹15 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Valiant Organics Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Bodal Chemicals Ltd (Q2 FY26)

    Q2 FY26 consolidated revenue from operations: Rs 4,804.5 mn, up 11.2% YoY from Rs 4,321.2 mn (Page 10). Key concall takeaways from Bodal Chemicals Ltd's Q2…

  • Chemcon Speciality Chemicals Ltd (Q2 FY26)

    Q2 FY26 revenue from operations: ₹53.7 crore, up 2% YoY (vs ₹52.6 crore in Q2 FY25) [Page 9, 6] . Key concall takeaways from Chemcon Speciality Chemicals Ltd's…

  • Indian Phosphate Ltd (Q2 FY26)

    H1 FY 25-26 revenue increased by ~15% to ₹451 crores versus ₹385 crores in H1 FY 24-25. Key concall takeaways from Indian Phosphate's Q2 FY26 earnings call…

  • Alkyl Amines Chemicals Ltd (Q2 FY26)

    120 crores. Key concall takeaways from Alkyl Amines Chemicals Ltd's Q2 FY26 earnings call — and how it ranks against sector peers.

Compare:vs Solar Industries India Ltdvs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Valiant Organics Ltd Q2 FY26 results?

Q2-FY26 consolidated revenue from operations: INR 1,573 million, down 1.8% year-on-year (Page 12). Q2-FY26 Consolidated Financial Highlights: - EBITDA: INR 212 Mn (up from INR 24 Mn in Q2-FY25) - Operating EBITDA Margin: 13.48% (up from 1.50% in Q2-FY25) - PAT: INR 57 Mn (compared to a loss of INR 125 Mn in Q2-FY25) - PAT Margin: 3.62% (compared to -7.80% in Q2-FY25) - Year-on-year change shows a significant turnaround in profitability and margin expansion.

What is Valiant Organics Ltd share price analysis?

Valiant Organics Ltd currently shows a neutral. The stock trades at a P/E of 23.7 with a market cap of ₹1,196 Cr. Investors should review the full earnings analysis for detailed insights.

Is Valiant Organics Ltd planning capital expenditure?

The investor presentation does not explicitly state any details regarding capex, capacity expansion, new plants, or projects with amounts, statuses, or timelines.

Keep Valiant Organics Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.